- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07841886
XRAIconnect Image Guidance Software for ERCP Procedures
XRAIconnect ERCP - A Single-center Feasibility Study of XRAIconnect Image Guidance Software for ERCP Procedures
The purpose of this research is to establish the usability, feasibility and utility of using XRAIconnect, a software medical device for operative image guidance for endoscopic retrograde cholangiopancreatography (ERCP) procedures. There will be prospective enrollment of up to 50 adult patients (18 years or older) undergoing elective ERCP procedures to evaluate the device clinically. Participants' pre-operative magnetic resonance cholangiopancreatography (MRCP) imaging data will be used to create digital, 3D reconstructions of the biliary and pancreatic ducts and surrounding organs/pathology. These 3D models will be aligned with live, intra-operative 2D X-ray (fluoroscopy) videos/images during ERCP in a process known as registration. This allows operators to view anatomical structures in 3D, with (stereoscopically) or without the use of an Augmented Reality HMD (Apple Vision Pro). To perform a registration to align 3D models to the intra-operative 2D images, natural anatomical landmarks that can be consistently identified on all images act as surrogate fiducial markers. The study aims to demonstrate that XRAIconnect can be used successfully during ERCP procedures, producing 3D models of sufficient accuracy.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Tamas Gonda, MD
- Numéro de téléphone: 646-501-2465
- E-mail: Tamas.gonda@nyulangone.org
Lieux d'étude
-
-
New York
-
New York, New York, États-Unis, 10016
- NYU Langone Health
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
-
Scheduled for an ERCP at NYU Langone Health (NYULH);
-
ERCP type:
- First time ERCP for any indication; OR
- ERCP (first-time or repeat) specifically for intrahepatic interventions, including placement of intrahepatic stent, access to intrahepatic stones, and access to intrahepatic strictures;
-
Aged 18 years or over;
-
Able to provide written consent to participate in the study (taken either in person during pre-ERCP hospital visit or by email via SendSafe);
-
Have pre-operative MRCP imaging data available to transfer to Medical iSight Corporation with sufficient time available for data processing using the medical device (XRAIconnect software) prior to use during the ERCP.
Exclusion Criteria:
- Preprocedural or intraprocedural imaging of insufficient quality;
- Pregnant or breastfeeding.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Faisabilité de l'appareil
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: ERCP Cases
Patients scheduled for an ERCP procedure will undergo pre-operative MRCP imaging scans (MRI scans) which will be reconstructed into digital, 3D models of the biliary and pancreatic ducts and surrounding organs/pathology. At the ERCP visit and using XRAIconnect software, NYULH ERCP operators will align these models with live, intra-operative 2D X-ray (fluoroscopy) videos/images (registration), allowing operators to view anatomical structures in 3D, with (stereoscopically) or without the use of an extended reality head-mounted display. The accuracy of XRAIconnect in terms of mean fiducial registration error and mean multiplanar triangulation error will be measured. |
Medical device software that generates three-dimensional (3D) geometric models from pre-operative imaging, and is capable of aligning them to live 2D fluoroscopic imaging during interventions, to provide enhanced navigational cues and a native 3D understanding of the spatial relationships between instrumentation and patient anatomy. In the context of ERCP, XRAIconnect uses data from pre-operative MRCP data to generate 3D models of the hepatobiliary system and surrounding structures which can be aligned with live, intra-operative 2D X-ray (fluoroscopy) videos/images during ERCP in a process known as registration. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Mean fiducial registration error
Délai: Approximately Week 8 (Day of Procedure)
|
Mean fiducial registration error is a measure of goodness of fit of the registration; measured in mm. |
Approximately Week 8 (Day of Procedure)
|
|
Mean multiplanar triangulation error
Délai: Approximately Week 8 (Day of Procedure)
|
Mean multiplanar triangulation error is the error due to small inconsistencies in registration across the imaging planes which may cause the resulting 3D rays cast not to intersect at a single, consistent point in space, leading to a slight mismatch between the 2D and 3D correspondences; measured in mm. |
Approximately Week 8 (Day of Procedure)
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
Fluoroscopy time
Délai: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Total procedure time
Délai: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Number of cannulation attempts
Délai: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Number of wires used
Délai: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Need for advanced cannulation techniques
Délai: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Post procedure complications within 24 hours
Délai: within 24 hours
|
within 24 hours
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Tamas Gonda, MD, NYU Langone Health
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- 26-00478
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Data will be specific to proprietary algorithm being studied in this trial and not relevant to outside researchers.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .